CellRight Technologies

Universal City, United States Founded: 2011 • Age: 15 yrs Acquired By Tissue Regenix
Orthobiologic scaffolds are developed for regenerative orthopedic therapies.
Request Access

About CellRight Technologies

CellRight Technologies is a company based in Universal City (United States) founded in 2011 was acquired by Tissue Regenix in August 2017.. CellRight Technologies offers products and services including DermaPure, OrthoPure XT, MatrixCellect, Matrix IQ Dermis, and DentalFix. CellRight Technologies operates in a competitive market with competitors including Inscripta, GenScript, OncoDNA, Sino Biological and Theradaptive, among others.

  • Headquarter Universal City, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Tissue Regenix

    (Aug 09, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CellRight Technologies

CellRight Technologies offers a comprehensive portfolio of products and services, including DermaPure, OrthoPure XT, MatrixCellect, Matrix IQ Dermis, and DentalFix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Regenerative product for skin and tissue repair applications

Technology for orthopaedic bone regeneration treatments

System for tissue processing in regenerative procedures

Product for dermal matrix in dental regeneration

Solution for dental tissue repair and support

Funding Insights of CellRight Technologies

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2026 Amount Private Equity Round - CellRight Technologies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CellRight Technologies

CellRight Technologies has secured backing from 1 investor. Prominent investors backing the company include Tissue Regenix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Developer of regenerative medical devices by using cell technology
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CellRight Technologies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CellRight Technologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cellright Technologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CellRight Technologies

CellRight Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, GenScript, OncoDNA, Sino Biological and Theradaptive, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Speech recognition solutions are provided by Inscripta for healthcare professionals.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Genomic and theranostic services for oncology precision medicine are delivered.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Therapeutic delivery platform is developed for orthopedic clinical indications.
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cellright Technologies

Frequently Asked Questions about CellRight Technologies

When was CellRight Technologies founded?

CellRight Technologies was founded in 2011 and raised its 1st funding round 15 years after it was founded.

Where is CellRight Technologies located?

CellRight Technologies is headquartered in Universal City, United States. It is registered at Universal City, California, United States.

What does CellRight Technologies do?

CellRight Technologies focuses on the field of regenerative medicine, developing osteoinductive and wound care scaffolds that are intended to enhance the healing of defects created by trauma and disease. The osteo-biologics may be used in spine, trauma, general orthopedic, foot ankle, dental, and sports medicine surgical procedures. The products are the Matrix OI Stem Cell Containment human scaffold (which uses the companys proprietary BioRinse technology), MatrixCellect 100 DBM putty (a demineralized bone matrix), MatrixCellect 100 DBM Crunch (a demineralized bone matrix containing mineralized cancellous chips), ConCelltrate 100 is an osteoinductive bone matrix, sports medicine products, Matrix IQ Dermis (human derived dermal grafts). conventional grafts, AmnioWorks (derived from human amniotic membrane), Matrix OI FlexIT, etc. The company is registered with the US FDA, accredited by the American Association of Tissue Banks (AATB), and registered with the Canadian Ministry of Health (CTO).

Who are the top competitors of CellRight Technologies?

CellRight Technologies's top competitors include Sino Biological, Theradaptive and OncoDNA.

What products or services does CellRight Technologies offer?

CellRight Technologies offers DermaPure, OrthoPure XT, MatrixCellect, Matrix IQ Dermis, and DentalFix.

Who are CellRight Technologies's investors?

CellRight Technologies has 1 investor. Key investors include Tissue Regenix.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available